Archipel Capital
VC Fund
Buffalo, United States
Archipel Capital is a venture capital firm specialized in in growth capital investments.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Archipel Capital invests in
Stages Archipel Capital invests in
Countries Archipel Capital invests in
Investment Focus
Industry
- Genetics 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lineagen
|
Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. | $12.2M / Series C / Jan 26, 2015 |
Co-Investors
HealthQuest Capital
1 deal together
Kickstart Ventures
1 deal together
Mesa Verde Venture Partners
1 deal together
Mountain Group Capital
1 deal together
Petra Capital Partners
1 deal together
PrairieGold Venture Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Archipel Capital invest in?
Archipel Capital invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Archipel Capital last invest?
The most recent investment recorded for Archipel Capital closed in Jan 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
